Nalaganje...
Amyloid imaging in clinical trials
The possibility to map amyloid-beta, the Alzheimer’s disease hallmark protein, in vivo opens the application for amyloid imaging in clinical trials with disease-modifying agents. Monitoring change in amyloid burden, particularly when potential amyloid-lowering drugs are at play, requires accurate an...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978734/ https://ncbi.nlm.nih.gov/pubmed/23953396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt195 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|